BOULDER, Colo., Nov. 22, 2016 /PRNewswire/ -- Array BioPharma Inc. ARRY today announced that its Chief Executive Officer, Ron Squarer, will speak at the Piper Jaffray Annual Healthcare conference. The public is welcome to participate in the conference through a webcast on the Array BioPharma website: www.arraybiopharma.com.
Event: |
Piper Jaffray Annual Healthcare Conference |
Date: |
Tuesday, November 29, 2016 |
Time: |
12:35 p.m. Eastern Standard Time |
About Array BioPharma
Array BioPharma Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of targeted small molecule drugs to treat patients afflicted with cancer. Five registration studies are currently advancing related to three cancer drugs. These programs include binimetinib (MEK162), encorafenib (LGX818) and selumetinib (AstraZeneca). For more information on Array, please go to http://www.arraybiopharma.com/.
CONTACT: |
Tricia Haugeto |
Array BioPharma Inc. | |
303-386-1193 | |
Logo - http://photos.prnewswire.com/prnh/20121029/LA02195LOGO
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/array-biopharma-to-present-at-the-piper-jaffray-annual-healthcare-conference-300365720.html
SOURCE Array BioPharma
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.